News Feed

PTX Metals Announces Flow Through Financing to Accelerate Activities and for Phase 2 Drilling at W2

(All figures are expressed in Canadian dollars unless otherwise indicated) TORONTO, April 17, 2024 (GLOBE NEWSWIRE) — PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”) is pleased to announce that the […]

News Feed

PLATINEX ANNOUNCES INCREASED FLOW THROUGH FINANCING AND RECEIPT OF STUDY RESULTS ON THE W2 COPPER-NICKEL-PGE PROJECT IN NORTHERN ONTARIO

Toronto, Ontario, December 1, 2023 – Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce that the Company has increased its previously announced flow through financing (see press release dated Nov 27, 2023) to […]

News Feed

PLATINEX MAKES NEW GOLD DISCOVERY AT HEENAN PROPERTY IN THE SWAYZE AREA OF THE ABITIBI GREENSTONE BELT

Toronto, Ontario, November 09, 2023 – Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce results from its exploration program on the Heenan Property, part of the Heenan Mallard Gold […]

News Feed

FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients

DENVER, Oct. 30, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of dysregulated immune responses including hyperinflammation on vital organs, announces that the U.S. […]

News Feed

FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces receipt of U.S. Food and Drug Administration […]